Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2014; 20(3): 795-803
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.795
Published online Jan 21, 2014. doi: 10.3748/wjg.v20.i3.795
Figure 5 Microarray assays in HepG2 and JHH6 following bortezomib treatment.
The mRNA levels of the indicated epithelial-mesenchymal transition (EMT) genes were evaluated by microarray analysis two days after HepG2 (A) or JHH6 (B) treatment by 40 nmol/L Bortezomib. Data are reported as ratio between treated cells (T) and non-treated cells (NT); data are shown as means ± SEM; aP < 0.05 vs controls; depending on the EMT member, the number of microarray evaluation ranged from three up to ten.
- Citation: Baiz D, Dapas B, Farra R, Scaggiante B, Pozzato G, Zanconati F, Fiotti N, Consoloni L, Chiaretti S, Grassi G. Bortezomib effect on E2F and cyclin family members in human hepatocellular carcinoma cell lines. World J Gastroenterol 2014; 20(3): 795-803
- URL: https://www.wjgnet.com/1007-9327/full/v20/i3/795.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i3.795